Previous close | 388.22 |
Open | 393.09 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's range | 390.59 - 394.74 |
52-week range | 310.42 - 415.73 |
Volume | |
Avg. volume | 551,768 |
Market cap | 28.85B |
Beta (5Y monthly) | 1.03 |
PE ratio (TTM) | 50.01 |
EPS (TTM) | 7.88 |
Earnings date | 25 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | 0.80 (0.20%) |
Ex-dividend date | 23 Apr 2024 |
1y target est | 400.43 |
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
West Pharmaceutical Services Inc (NYSE:WST), a global leader in the design and production of containment and delivery systems for injectable drugs and healthcare products, has reported an insider sell according to a recent SEC filing.